These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8754338)

  • 1. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
    Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive treatment of migraine with vasobral: a multicenter trial].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):26-30. PubMed ID: 21389936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
    Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR
    Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical efficacy of tanakan in patients with stage-I atherosclerotic circulatory encephalopathy].
    Rudenko AE; Lushchik UB; Dzhumik VA
    Lik Sprava; 1997; (2):99-101. PubMed ID: 9333499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasobral in the treatment of brain lesions: views of physicians and patients].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):23-5. PubMed ID: 23528488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
    Sadekov RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):43-5. PubMed ID: 11195537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of cerebrovascular insufficiency].
    Cosentino F; Baldassarri R
    Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of vasobral in therapy of central nervous system pathology in children of early age].
    Zaĭtseva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Bachinskaia NIu; Kochubeĭ NV
    Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
    Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV
    Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 16. DEM and cerebral arteriosclerosis.
    Cox SS
    J Am Geriatr Soc; 1983 Aug; 31(8):510-11. PubMed ID: 6875159
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of treatment with the tranquilizer tranxene in elderly persons with psychoemotional disorders against a background of initial and moderately pronounced atherosclerotic circulatory encephalopathy].
    Grebel'nik VI
    Lik Sprava; 1995; (7-8):29-32. PubMed ID: 8846366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The drug correction of disorders in the erythrocyte structural-functional properties of patients with atherosclerotic circulatory encephalopathy].
    Voloshin PV; Iavorskaia VA; Malakhov VA
    Vrach Delo; 1991 Apr; (4):59-62. PubMed ID: 2063570
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of vasobral in patients with chronic cerebrovascular disorders].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):70-2. PubMed ID: 22500318
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.